These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 29721633)

  • 1. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
    Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
    Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-sectional and Test-Retest Characterization of PET with [(18)F]FP-(+)-DTBZ for β Cell Mass Estimates in Diabetes.
    Freeby MJ; Kringas P; Goland RS; Leibel RL; Maffei A; Divgi C; Ichise M; Harris PE
    Mol Imaging Biol; 2016 Apr; 18(2):292-301. PubMed ID: 26370678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular monoamine transporter, type 2 (VMAT2) expression as it compares to insulin and pancreatic polypeptide in the head, body and tail of the human pancreas.
    Freeby M; Ichise M; Harris PE
    Islets; 2012; 4(6):393-7. PubMed ID: 23221614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of endogenous pancreatic β-cell mass in healthy and type 1 diabetic subjects using 18F-fluoropropyl-dihydrotetrabenazine and PET.
    Normandin MD; Petersen KF; Ding YS; Lin SF; Naik S; Fowles K; Skovronsky DM; Herold KC; McCarthy TJ; Calle RA; Carson RE; Treadway JL; Cline GW
    J Nucl Med; 2012 Jun; 53(6):908-16. PubMed ID: 22573821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.
    Goland R; Freeby M; Parsey R; Saisho Y; Kumar D; Simpson N; Hirsch J; Prince M; Maffei A; Mann JJ; Butler PC; Van Heertum R; Leibel RL; Ichise M; Harris PE
    J Nucl Med; 2009 Mar; 50(3):382-9. PubMed ID: 19223416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo imaging of beta-cell mass in rats using 18F-FP-(+)-DTBZ: a potential PET ligand for studying diabetes mellitus.
    Kung MP; Hou C; Lieberman BP; Oya S; Ponde DE; Blankemeyer E; Skovronsky D; Kilbourn MR; Kung HF
    J Nucl Med; 2008 Jul; 49(7):1171-6. PubMed ID: 18552132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET Imaging of Pancreatic Dopamine D
    Bini J; Sanchez-Rangel E; Gallezot JD; Naganawa M; Nabulsi N; Lim K; Najafzadeh S; Shirali A; Ropchan J; Matuskey D; Huang Y; Herold KC; Harris PE; Sherwin RS; Carson RE; Cline GW
    J Nucl Med; 2020 Apr; 61(4):570-576. PubMed ID: 31601695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.
    Freeby M; Goland R; Ichise M; Maffei A; Leibel R; Harris P
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():98-108. PubMed ID: 18834437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Species-specific vesicular monoamine transporter 2 (VMAT2) expression in mammalian pancreatic beta cells: implications for optimising radioligand-based human beta cell mass (BCM) imaging in animal models.
    Schäfer MK; Hartwig NR; Kalmbach N; Klietz M; Anlauf M; Eiden LE; Weihe E
    Diabetologia; 2013 May; 56(5):1047-56. PubMed ID: 23404442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise training decreases pancreatic fat content and improves beta cell function regardless of baseline glucose tolerance: a randomised controlled trial.
    Heiskanen MA; Motiani KK; Mari A; Saunavaara V; Eskelinen JJ; Virtanen KA; Koivumäki M; Löyttyniemi E; Nuutila P; Kalliokoski KK; Hannukainen JC
    Diabetologia; 2018 Aug; 61(8):1817-1828. PubMed ID: 29717337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Pancreatic VMAT2 Binding with Active and Inactive Enantiomers of [
    Naganawa M; Lim K; Nabulsi NB; Lin SF; Labaree D; Ropchan J; Herold KC; Huang Y; Harris P; Ichise M; Cline GW; Carson RE
    Mol Imaging Biol; 2018 Oct; 20(5):835-845. PubMed ID: 29468404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenzazine (AV-133) to the vesicular monoamine transporter type 2 in rats.
    Tsao HH; Lin KJ; Juang JH; Skovronsky DM; Yen TC; Wey SP; Kung MP
    Nucl Med Biol; 2010 May; 37(4):413-9. PubMed ID: 20447551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET quantification of pancreatic VMAT 2 binding using (+) and (-) enantiomers of [¹⁸F]FP-DTBZ in baboons.
    Harris PE; Farwell MD; Ichise M
    Nucl Med Biol; 2013 Jan; 40(1):60-4. PubMed ID: 23102539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal noninvasive PET-based beta cell mass estimates in a spontaneous diabetes rat model.
    Souza F; Simpson N; Raffo A; Saxena C; Maffei A; Hardy M; Kilbourn M; Goland R; Leibel R; Mann JJ; Van Heertum R; Harris PE
    J Clin Invest; 2006 Jun; 116(6):1506-13. PubMed ID: 16710474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of PET Brain Radioligands for Imaging Pancreatic β-Cell Mass: Potential Utility of
    Bini J; Naganawa M; Nabulsi N; Huang Y; Ropchan J; Lim K; Najafzadeh S; Herold KC; Cline GW; Carson RE
    J Nucl Med; 2018 Aug; 59(8):1249-1254. PubMed ID: 29371405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of pancreatic VMAT2 binding with active and inactive enantiomers of
    Naganawa M; Lin SF; Lim K; Labaree D; Ropchan J; Harris P; Huang Y; Ichise M; Carson RE; Cline GW
    Nucl Med Biol; 2016 Dec; 43(12):743-751. PubMed ID: 27673755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging of vesicular monoamine transporter 2 in pancreas using an (18)F epoxide derivative of tetrabenazine.
    Kung HF; Lieberman BP; Zhuang ZP; Oya S; Kung MP; Choi SR; Poessl K; Blankemeyer E; Hou C; Skovronsky D; Kilbourn M
    Nucl Med Biol; 2008 Nov; 35(8):825-37. PubMed ID: 19026944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas.
    Saisho Y; Harris PE; Butler AE; Galasso R; Gurlo T; Rizza RA; Butler PC
    J Mol Histol; 2008 Oct; 39(5):543-51. PubMed ID: 18791800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.